Pablo J Cagnoni Rubius Therapeutics, Inc. (RUBY) insider trading activity

Pablo J Cagnoni is Director of Rubius Therapeutics, Inc.. Currently has a direct ownership of 66,082 shares of RUBY, which is worth approximately $0. The most recent transaction as insider was on Feb 01, 2023, when has been sold 8,448 shares (Common Stock) at a price of $0.25 per share, resulting in proceeds of $2,112. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.1K

0% 3M change

0% 12M change

Total Value Held $0

PABLO J CAGNONI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2023	SELL Open market or private sale	$2,112 $0.25 p/Share	8,448 Reduced 11.34%	66,082 Common Stock
Jan 31 2023	SELL Open market or private sale	$1,737 $0.24 p/Share	7,240 Reduced 8.85%	74,530 Common Stock
Jan 31 2023	BUY Exercise of conversion of derivative security	-	25,000 Added 23.41%	81,770 Common Stock
Jan 29 2023	BUY Exercise of conversion of derivative security	-	21,250 Added 27.24%	56,770 Common Stock
Feb 01 2022	SELL Open market or private sale	$44,216 $6.57 p/Share	6,730 Reduced 15.93%	35,520 Common Stock
Jan 29 2022	BUY Exercise of conversion of derivative security	-	21,250 Added 33.46%	42,250 Common Stock

Also insider at

CRSP

CRISPR Therapeutics AG Healthcare

Director

FUSN

Fusion Pharmaceuticals Inc. Healthcare

INCY

INCYTE CORP Healthcare

President, R&D

PJC

Pablo J Cagnoni

Director

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RUBY shares.

Notify only if

Value

Insider Trading

Get notified when an Rubius Therapeutics, Inc. insider buys or sells RUBY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Rubius Therapeutics, Inc.

Track Activities on RUBY

Account